Celebrating three decades of Huntington’s Disease Service at Westmead Hospital is not just a milestone; it marks a significant evolution in understanding and support for those living with this challenging condition. Recently, the service commemorated its 30th anniversary alongside the Huntington support association, which proudly celebrated its 50th year of providing advocacy and assistance.
Throughout much of the twentieth century, Huntington's Disease was often misunderstood and shrouded in stigma. The groundbreaking efforts of dedicated individuals, organizations, and healthcare professionals in the mid-1970s played a crucial role in dismantling barriers and fostering connections among families affected by this neurodegenerative disorder.
Huntington’s Disease (HD) is a rare genetic condition that can lead to profound isolation for those diagnosed, as it is not only devastating but also relatively uncommon. Symptoms tend to manifest subtly, usually between the ages of 30 and 50, affecting movement, cognition, and emotional well-being. What may start as minor twitches can progressively escalate into severe mobility challenges over several decades.
Professor Clement Loy, who has been at the helm of the Westmead HD Service for the last 16 years, shared insights into the service's journey. He noted, "Before the 1970s, there was little specific medical help available for families grappling with HD."
He acknowledged the significant contributions of two inspiring women. "Robyn Kapp OAM served as the cornerstone of Huntington’s NSW, the primary patient support organization, for nearly four decades. She was instrumental in establishing HD services at Lidcombe Hospital," Dr. Loy remarked.
Additionally, he highlighted the efforts of Professor Elizabeth McCusker OAM, who launched the first HD clinic at Lidcombe Hospital in 1988. Following the closure of Lidcombe in 1995, Prof. McCusker was determined to create a comprehensive multidisciplinary service capable of addressing the diverse needs of HD families. Westmead Hospital responded to this urgent call for support.
The identification of the gene responsible for HD in 1993 was a pivotal moment, offering families the opportunity to understand their risk of inheriting this life-altering condition. Each child of a parent with the HD gene expansion faces a 50/50 chance of developing the disease. Adults wishing to know their genetic status can undergo testing to determine if they carry the gene.
In collaboration with geneticists and counselors, the Westmead HD Service has established vital genetic services, assisting families in navigating the difficult decision of whether to pursue genetic testing.
Today, the Huntington’s Disease Service at Westmead continues its mission by providing an extensive array of neurological and allied health support. They also offer outreach services across New South Wales, engage in clinical trials and observational studies, and contribute to both national and international research initiatives.
During the recent anniversary celebration, organized by Dr. Therese Alting and her team, attendees had the opportunity to honor those who have tirelessly worked to enhance the lives of individuals affected by this complex genetic disorder.
Lenni Duffield, CEO of Huntington’s Australia, participated in the festivities and emphasized the critical importance of community support. "Finding your people and your community instills hope. You realize you’re not alone, that others understand your experience, and there's a level of empathy where you don’t have to keep retelling your story," Lenni explained.
Huntington’s Australia is dedicated to supporting approximately 2,200 individuals in Australia who exhibit symptoms of the disease, along with their families, caregivers, and others at risk.
While researchers continue to search for a cure, there are encouraging advancements in symptomatic treatments that greatly benefit patients. Moreover, there is growing optimism surrounding ongoing genetic trials, shedding light on potential future therapies.
